ivermectin oral / Generic mfg. 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 


«12...107108109110111112113114115116117...129130»
  • ||||||||||  ivermectin / Generic mfg.
    Review, Journal:  Onchocerciasis Elimination: Progress and Challenges. (Pubmed Central) -  Nov 1, 2020   
    The impact of mass treatment with ivermectin and supplemented by vector control in some countries has changed the global scene of onchocerciasis...However, programs are challenged with a range of issues: cross-border transmission, diagnostic tools, Loa loa co-endemicity, limited workforce in entomology and maintaining enthusiasm among community drug distributors. More concerted effort using appropriate tools is required to overcome the challenges.
  • ||||||||||  ivermectin / Generic mfg.
    Journal:  Dysbiosis associated with acute helminth infections in herbivorous youngstock - observations and implications. (Pubmed Central) -  Oct 31, 2020   
    This study investigates, for the first time, the associations between acute infections by GI helminths and the faecal microbial and metabolic profiles of a cohort of equine youngstock, prior to and following treatment with parasiticides (ivermectin)...These data support the hypothesis that GI helminth infections in young livestock are associated with significant alterations to the GI microbiota, which may impact on both metabolism and development of acquired immunity. This knowledge will direct future studies aimed to identify the long-term impact of infection-induced alterations of the GI microbiota in young livestock.
  • ||||||||||  ivermectin / Generic mfg.
    Preclinical, Journal:  Nebulized ivermectin for COVID-19 and other respiratory diseases, a proof of concept, dose-ranging study in rats. (Pubmed Central) -  Oct 30, 2020   
    All subjects had detectable ivermectin concentrations in the lungs at seven days post intervention, up to 524.3 ng/g for high-dose male and 27.3 ng/g for low-dose females. nebulized ivermectin can reach pharmacodynamic concentrations in the lung tissue of rats, additional experiments are required to assess the safety of this formulation in larger animals.
  • ||||||||||  ivermectin / Generic mfg., levamisole / Generic mfg.
    Clinical, Journal:  Economic losses caused by the use of low-efficacy anthelmintic drugs in growing heifers. (Pubmed Central) -  Oct 24, 2020   
    These results showed that it would be preferable not to treat the heifers against GIN if compared with treating them with a low-efficacy drug. In addition, we showed that the use of four treatments per year with a high-efficacy drug-selected by efficacy test-resulted in a profitable management to control GIN in growing heifers raised in a semi-intensive gazing system in southern Brazil.
  • ||||||||||  acetazolamide / Generic mfg., sildenafil / Generic mfg., ivermectin / Generic mfg.
    Clinical, Journal:  Three novel prevention, diagnostic, and treatment options for COVID-19 urgently necessitating controlled randomized trials. (Pubmed Central) -  Oct 24, 2020   
    Digital monitoring of symptoms to clinically diagnose early exposure and response to treatment; prevention with ivermectin as well as nutritional therapies that support a healthy immune response; treatment with anti-inflammatory therapies that block NF-κB and activate Nrf2 pathways, as well as novel therapies that address COVID-19 pneumonia and ARDS with DIC including anticoagulation and/or novel respiratory therapies with or without acetazolamide and sildenafil. These three broad-based interventions urgently need to be subjected to randomized, controlled trials.
  • ||||||||||  prednisone / Generic mfg., ivermectin / Generic mfg.
    [VIRTUAL] A Case of Strongyloides hyperinfection Syndrome Mimicking a Drug Rash () -  Oct 23, 2020 - Abstract #ASDS2020ASDS_165;    
    Interestingly, our patient did not present with recent travel history or the characteristic larva currens rash. His Strongyloidiasis was likely reactivated in the setting of recent initiation of low-dose prednisone for metastatic prostate cancer, leading to hyperinfection syndrome.
  • ||||||||||  ivermectin oral / Generic mfg.
    Trial primary completion date:  COVidIVERmectin: Ivermectin for Treatment of Covid-19 (clinicaltrials.gov) -  Oct 22, 2020   
    P2,  N=102, Recruiting, 
    His Strongyloidiasis was likely reactivated in the setting of recent initiation of low-dose prednisone for metastatic prostate cancer, leading to hyperinfection syndrome. Trial primary completion date: Aug 2020 --> Dec 2020
  • ||||||||||  doxycycline / Generic mfg.
    Trial completion date, Trial primary completion date:  Efficacy and Safety of Ivermectin and Doxycycline in Combination or IVE Alone in Patients With COVID-19 Infection. (clinicaltrials.gov) -  Oct 21, 2020   
    P2,  N=72, Enrolling by invitation, 
    These results are discussed with respect to the interaction of the doctor-patient relationship and the holistic nature of primary care, potentially triggering burnout and empathy decrease and negatively impacting the quality of care in precarious populations. Trial completion date: Jul 2020 --> Oct 2020 | Trial primary completion date: Jul 2020 --> Oct 2020
  • ||||||||||  ivermectin / Generic mfg.
    Review, Journal:  Ivermectin: A Closer Look at a Potential Remedy. (Pubmed Central) -  Oct 20, 2020   
    Contrastingly, hydroxychloroquine has been a controversial drug in the management of COVID-19...However, its survival benefit in patients with COVID-19 has not been documented. We herein propose the theory of inhaled ivermectin which can attain the desired lung concentration that will render it effective against SARS-CoV-2.
  • ||||||||||  ivermectin / Generic mfg.
    Clinical, Journal:  Clinical, serological and DNA testing in Bengo Province, Angola further reveals low filarial endemicity and opportunities for disease elimination. (Pubmed Central) -  Oct 19, 2020   
    For O. volvulus, 4.7% (n = 74/1567) individuals were found to be positive by enzyme-linked immunosorbent assay (Ov 16 ELISA), with only three individuals reporting to have ever taken ivermectin...Our approach of using combination diagnostics reveals the age-prevalence of loiasis alongside low endemicity of onchocerciasis and LF. Future research foci should be on identifying opportunities for more cost-effective ways to eliminate onchocerciasis and to develop innovative surveillance modalities for clinical LF for individual disease management and disability prevention.
  • ||||||||||  famotidine / Generic mfg., ivermectin / Generic mfg., doxycycline / Generic mfg., Pierre Fabre
    Journal:  Ivermectin, Famotidine, and Doxycycline: A Suggested Combinatorial Therapeutic for the Treatment of COVID-19. (Pubmed Central) -  Oct 19, 2020   
    At times, combination therapy has proven to be very effective. While no cure is available to date, herein we put forward with rationale and supporting evidence that if administrated simultaneously, a combination of FDA-approved drugs comprising ivermectin, famotidine, and doxycycline may provide robust chemoprophylaxis effective against COVID-19.
  • ||||||||||  ivermectin oral / Generic mfg.
    Trial completion, Enrollment change:  IVERCAR: USEFULNESS of Topic Ivermectin and Carrageenan to Prevent Contagion of Covid 19 (clinicaltrials.gov) -  Oct 19, 2020   
    P=N/A,  N=229, Completed, 
    While no cure is available to date, herein we put forward with rationale and supporting evidence that if administrated simultaneously, a combination of FDA-approved drugs comprising ivermectin, famotidine, and doxycycline may provide robust chemoprophylaxis effective against COVID-19. Active, not recruiting --> Completed | N=70 --> 229
  • ||||||||||  aspirin / Generic mfg., enoxaparin sodium / Generic mfg.
    Trial completion, Enrollment change:  Ivermectin, Aspirin, Dexamethasone and Enoxaparin as Treatment of Covid 19 (clinicaltrials.gov) -  Oct 19, 2020   
    P=N/A,  N=167, Completed, 
    Active, not recruiting --> Completed | N=70 --> 229 Active, not recruiting --> Completed | N=100 --> 167